MHAT Haskovo

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Heart failure2 trials
• Stroke1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Completed1 trial
• Terminated1 trial

Lead sponsor

• Bayer1 trial
• Regeneron Pharmaceuticals1 trial

Closed trials

• Terminated

  REGN5381 in Adult Participants With Heart Failure With Reduced Ejection Fraction

  NCT06237309· Phase 2· Regeneron Pharmaceuticals· Source

• Completed

  Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

  NCT04435626· Phase 3· Bayer· Source